Answers are grounded in this paper and cite their sources.
As a consequence of its specific mechanism of action, bacterial resistance is unlikely to develop. In our 3 cases, resistance induction was not observed. Our results indicate that targeted treatment with Staphefekt might be an attractive alternative for (long-term) classical antibiotic therapy, and confirmatory randomized controlled trials are warranted to evaluate its clinical efficacy and safety.
No takes yet. Share an insight, caveat, or question.
Totté et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: